1. Pereira L, Freitas F, Fernandes V, Pereira JB, Costa MD, Costa S, Máximo V, Macaulay V, Rocha R, Samuels DC

The diversity present in 5140 human mitochondrial genomes. American journal of human genetics 84: 628-40, 2009.  [Article] 

 doi: 10.1016/j.ajhg.2009.04.013 PMID: 19426953.

 

2. Máximo V, Soares P, Machado JC, Seruca R, Sobrinho-Simões M

Mitochondrial DNA alteration in gastric cancer. Gastroenterology 119: 1808-9, 2000.  [Letter] 

 PMID: 11187439.

 

3. Vinagre J, Almeida A, Pópulo H, Batista R, Lyra J, Pinto V, Coelho R, Celestino R, Prazeres H, Lima L, Melo M, Rocha AG, Preto A, Castro P, Castro L, Pardal F, Lopes JM, Santos LL, Reis RM, Cameselle-Teijeiro J, Sobrinho-Simões M, Lima J, Máximo V, Soares P

Frequency of TERT promoter mutations in human cancers. Nature communications 4: 2185, 2013.  [Article] 

 doi: 10.1038/ncomms3185 PMID: 23887589.

 

4. Correia M, Pinheiro P, Batista R, Soares P, Sobrinho-Simões M, Máximo V

Etiopathogenesis of oncocytomas. Seminars in cancer biology 47: 82-94, 2017.  [Review] 

 doi: 10.1016/j.semcancer.2017.06.014 PMID: 28687249.

 

5. Couto JP, Daly L, Almeida A, Knauf JA, Fagin JA, Sobrinho-Simões M, Lima J, Máximo V, Soares P, Lyden D, Bromberg JF

STAT3 negatively regulates thyroid tumorigenesis. Proceedings of the National Academy of Sciences of the United States of America 109: E2361-70, 2012.  [Article] 

 doi: 10.1073/pnas.1201232109 PMID: 22891351.

 

6. Pertega-Gomes N, Felisbino S, Massie CE, Vizcaino JR, Coelho R, Sandi C, Simoes-Sousa S, Jurmeister S, Ramos-Montoya A, Asim M, Tran M, Oliveira E, Lobo da Cunha A, Maximo V, Baltazar F, Neal DE, Fryer LG

A glycolytic phenotype is associated with prostate cancer progression and aggressiveness: a role for monocarboxylate transporters as metabolic targets for therapy. The Journal of pathology 236: 517-30, 2015.  [Article] 

 doi: 10.1002/path.4547 PMID: 25875424.

 

7. Máximo V, Soares P, Lima J, Cameselle-Teijeiro J, Sobrinho-Simões M

Mitochondrial DNA somatic mutations (point mutations and large deletions) and mitochondrial DNA variants in human thyroid pathology: a study with emphasis on Hürthle cell tumors. The American journal of pathology 160: 1857-65, 2002.  [Article] 

 PMID: 12000737.

 

8. Machado AM, Figueiredo C, Touati E, Máximo V, Sousa S, Michel V, Carneiro F, Nielsen FC, Seruca R, Rasmussen LJ

Helicobacter pylori infection induces genetic instability of nuclear and mitochondrial DNA in gastric cells. Clinical cancer research : an official journal of the American Association for Cancer Research 15: 2995-3002, 2009.  [Article] 

 doi: 10.1158/1078-0432.CCR-08-2686 PMID: 19383819.

 

9. Batista R, Cruvinel-Carloni A, Vinagre J, Peixoto J, Catarino TA, Campanella NC, Menezes W, Becker AP, de Almeida GC, Matsushita MM, Clara C, Neder L, Viana-Pereira M, Honavar M, Castro L, Lopes JM, Carvalho B, Vaz RM, Máximo V, Soares P, Sobrinho-Simões M, Reis RM, Lima J

The prognostic impact of TERT promoter mutations in glioblastomas is modified by the rs2853669 single nucleotide polymorphism. International journal of cancer 139: 414-23, 2016.  [Article] 

 doi: 10.1002/ijc.30057 PMID: 26914704.

 

10. Soares P, Trovisco V, Rocha AS, Lima J, Castro P, Preto A, Máximo V, Botelho T, Seruca R, Sobrinho-Simões M

BRAF mutations and RET/PTC rearrangements are alternative events in the etiopathogenesis of PTC. Oncogene 22: 4578-80, 2003.  [Article] 

 doi: 10.1038/sj.onc.1206706 PMID: 12881714.

 

11. Melo M, da Rocha AG, Vinagre J, Batista R, Peixoto J, Tavares C, Celestino R, Almeida A, Salgado C, Eloy C, Castro P, Prazeres H, Lima J, Amaro T, Lobo C, Martins MJ, Moura M, Cavaco B, Leite V, Cameselle-Teijeiro JM, Carrilho F, Carvalheiro M, Máximo V, Sobrinho-Simões M, Soares P

TERT Promoter Mutations Are a Major Indicator of Poor Outcome in Differentiated Thyroid Carcinomas. The Journal of clinical endocrinology and metabolism 99: E754-65, 2014.  [Article] 

 doi: 10.1210/jc.2013-3734 PMID: 24476079.

 

12. Nunes JB, Peixoto J, Soares P, Maximo V, Carvalho S, Pinho SS, Vieira AF, Paredes J, Rego AC, Ferreira IL, Gomez-Lazaro M, Sobrinho-Simoes M, Singh KK, Lima J

OXPHOS dysfunction regulates integrin-ß1 modifications and enhances cell motility and migration. Human molecular genetics 24: 1977-90, 2015.  [Article] 

 doi: 10.1093/hmg/ddu612 PMID: 25504047.

 

13. Lima J, Teixeira-Gomes J, Soares P, Máximo V, Honavar M, Williams D, Sobrinho-Simões M

Germline succinate dehydrogenase subunit D mutation segregating with familial non-RET C cell hyperplasia. The Journal of clinical endocrinology and metabolism 88: 4932-7, 2003.  [Article] 

 PMID: 14557476.

 

14. da Silva AF, Mariotti FR, Máximo V, Campello S

Mitochondria dynamism: of shape, transport and cell migration. Cellular and molecular life sciences : CMLS 71: 2313-24, 2014.  [Review] 

 doi: 10.1007/s00018-014-1557-8 PMID: 24442478.

 

15. Lima J, Trovisco V, Soares P, Máximo V, Magalhães J, Salvatore G, Santoro M, Bogdanova T, Tronko M, Abrosimov A, Jeremiah S, Thomas G, Williams D, Sobrinho-Simões M

BRAF mutations are not a major event in post-Chernobyl childhood thyroid carcinomas. The Journal of clinical endocrinology and metabolism 89: 4267-71, 2004.  [Article] 

 doi: 10.1210/jc.2003-032224 PMID: 15356020.

 

16. Gonçalves AP, Máximo V, Lima J, Singh KK, Soares P, Videira A

Involvement of p53 in cell death following cell cycle arrest and mitotic catastrophe induced by rotenone. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH  1813: 492-9, 2011.  [Article] 

 doi: 10.1016/j.bbamcr.2011.01.006 PMID: 21223980.

 

17. Lima J, Feijão T, Ferreira da Silva A, Pereira-Castro I, Fernandez-Ballester G, Máximo V, Herrero A, Serrano L, Sobrinho-Simões M, Garcia-Rostan G

High frequency of germline succinate dehydrogenase mutations in sporadic cervical paragangliomas in northern Spain: mitochondrial succinate dehydrogenase structure-function relationships and clinical-pathological correlations. The Journal of clinical endocrinology and metabolism 92: 4853-64, 2007.  [Article] 

 doi: 10.1210/jc.2007-0640 PMID: 17848412.

 

18. Trovisco V, Vieira de Castro I, Soares P, Máximo V, Silva P, Magalhães J, Abrosimov A, Guiu XM, Sobrinho-Simões M

BRAF mutations are associated with some histological types of papillary thyroid carcinoma. The Journal of pathology 202: 247-51, 2004.  [Article] 

 doi: 10.1002/path.1511 PMID: 14743508.

 

19. Máximo V, Lima J, Prazeres H, Soares P, Sobrinho-Simões M

The biology and the genetics of Hurthle cell tumors of the thyroid. Endocrine-related cancer 19: R131-47, 2012.  [Review] 

 doi: 10.1530/ERC-11-0354 PMID: 22514109.

 

20. Rocha AS, Soares P, Seruca R, Máximo V, Matias-Guiu X, Cameselle-Teijeiro J, Sobrinho-Simões M

Abnormalities of the E-cadherin/catenin adhesion complex in classical papillary thyroid carcinoma and in its diffuse sclerosing variant. The Journal of pathology 194: 358-66, 2001.  [Article] 

 doi: 10.1002/path.905 PMID: 11439369.

 

21. Ferreira AC, Gomes L, Máximo V, Amil J, Carneiro F, Machado JC, Tavarela-Veloso F

GRIM-19 mutations are not associated with Crohn's disease. Inflammatory bowel diseases 14: 434-5, 2008.  [Letter] 

 doi: 10.1002/ibd.20313 PMID: 18022871.

 

22. Martins RG, Nunes JB, Máximo V, Soares P, Peixoto J, Catarino T, Rito T, Soares P, Pereira L, Sobrinho-Simões M, Santos AP, Couto J, Henrique R, Matos-Loureiro J, Dias P, Torres I, Lima J

A founder SDHB mutation in Portuguese paraganglioma patients. Endocrine-related cancer 20: L23-6, 2013.  [Letter] 

 doi: 10.1530/ERC-12-0399 PMID: 24092654.

 

23. Pópulo H, Caldas R, Lopes JM, Pardal J, Máximo V, Soares P

Overexpression of pyruvate dehydrogenase kinase supports dichloroacetate as a candidate for cutaneous melanoma therapy. Expert opinion on therapeutic targets 19: 733-45, 2015.  [Article] 

 doi: 10.1517/14728222.2015.1045416 PMID: 25976231.

 

24. Lima J, Máximo V, Soares P, Williams D, Bogdanova T, Thomas GA, Sobrinho-Simões M

Re: Lohrer,H.D., Hieber,L. and Zitzelsberger,H. (2002) Differential mutation frequency in mitochondrial DNA from thyroid tumours. Carcinogenesis, 23, 1577-1582. Carcinogenesis 24: 1155, 2003.  [Letter] 

 doi: 10.1093/carcin/bgg050 PMID: 12807747.

 

25. Máximo V, Soares P, Seruca R, Rocha AS, Castro P, Sobrinho-Simões M

Microsatellite instability, mitochondrial DNA large deletions, and mitochondrial DNA mutations in gastric carcinoma. Genes, chromosomes & cancer 32: 136-43, 2001.  [Article] 

 PMID: 11550281.

 

26. Celestino R, Lima J, Faustino A, Vinagre J, Máximo V, Gouveia A, Soares P, Lopes JM

Molecular alterations and expression of succinate dehydrogenase complex in wild-type KIT/PDGFRA/BRAF gastrointestinal stromal tumors. European journal of human genetics : EJHG 21: 503-10, 2013.  [Article] 

 doi: 10.1038/ejhg.2012.205 PMID: 22948025.

 

27. Lima J, Máximo V, Soares P, Sobrinho-Simões M

Alterations of the SDHD gene locus in midgut carcinoids. Genes, chromosomes & cancer 36: 424, 2003.  [Letter] 

 doi: 10.1002/gcc.10147 PMID: 12619155.

 

28. Máximo V, Sobrinho-Simões M

Mitochondrial DNA 'common' deletion in Hürthle cell lesions of the thyroid. The Journal of pathology 192: 561-2, 2000.  [Letter] 

 doi: 10.1002/1096-9896(200012)192:4<561::AID-PATH790>3.0.CO;2-3 PMID: 11113879.

 

29. Máximo V, Botelho T, Capela J, Soares P, Lima J, Taveira A, Amaro T, Barbosa AP, Preto A, Harach HR, Williams D, Sobrinho-Simões M

Somatic and germline mutation in GRIM-19, a dual function gene involved in mitochondrial metabolism and cell death, is linked to mitochondrion-rich (Hurthle cell) tumours of the thyroid. British journal of cancer 92: 1892-8, 2005.  [Article] 

 doi: 10.1038/sj.bjc.6602547 PMID: 15841082.

 

30. Máximo V, Lima J, Soares P, Silva A, Bento I, Sobrinho-Simões M

GRIM-19 in Health and Disease. Advances in anatomic pathology 15: 46-53, 2008.  [Editorial Material] 

 doi: 10.1097/PAP.0b013e31815e5258 PMID: 18156812.

 

31. Silva LS, Goncalves LG, Silva F, Domingues G, Maximo V, Ferreira J, Lam EW, Dias S, Felix A, Serpa J

STAT3:FOXM1 and MCT1 drive uterine cervix carcinoma fitness to a lactate-rich microenvironment. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 37: 5385-95, 2016.  [Article] 

 doi: 10.1007/s13277-015-4385-z PMID: 26563366.

 

32. Moreira S, Correia M, Soares P, Máximo V

GRIM-19 function in cancer development. Mitochondrion 11: 693-9, 2011.  [Review] 

 doi: 10.1016/j.mito.2011.05.011 PMID: 21664299.

 

33. Boaventura P, Pereira D, Mendes A, Batista R, da Silva AF, Guimarães I, Honavar M, Teixeira-Gomes J, Lopes JM, Máximo V, Soares P

Mitochondrial D310 D-Loop instability and histological subtypes in radiation-induced cutaneous basal cell carcinomas. Journal of dermatological science 73: 31-9, 2014.  [Article] 

 doi: 10.1016/j.jdermsci.2013.09.002 PMID: 24091058.

 

34. Lima AR, Santos L, Correia M, Soares P, Sobrinho-Simões M, Melo M, Máximo V

Dynamin-Related Protein 1 at the Crossroads of Cancer. Genes 9: ., 2018.  [Review] 

 doi: 10.3390/genes9020115 PMID: 29466320.

 

35. Manco L, Ribeiro ML, Máximo V, Almeida H, Costa A, Freitas O, Barbot J, Abade A, Tamagnini G

A new PKLR gene mutation in the R-type promoter region affects the gene transcription causing pyruvate kinase deficiency. British journal of haematology 110: 993-7, 2000.  [Article] 

 PMID: 11054094.

 

36. Ferreira-da-Silva A, Valacca C, Rios E, Pópulo H, Soares P, Sobrinho-Simões M, Scorrano L, Máximo V, Campello S

Mitochondrial dynamics protein Drp1 is overexpressed in oncocytic thyroid tumors and regulates cancer cell migration. PloS one 10: e0122308, 2015.  [Article] 

 doi: 10.1371/journal.pone.0122308 PMID: 25822260.

 

37. Lima J, Trovisco V, Soares P, Máximo V, Magalhães J, Salvatore G, Santoro M, Bogdanova T, Tronko M, Abrosimov A, Jeremiah S, Thomas G, Williams D, Sobrinho-Simões M

Reply to: Low prevalence of BRAF mutations in radiation-induced thyroid tumors in contrast to sporadic papillary carcinomas. Cancer letters 230: 149-50, 2005.  [Letter] 

 doi: 10.1016/j.canlet.2004.10.053 PMID: 16253771.

 

38. Pereira SS, Máximo V, Coelho R, Batista R, Soares P, Guerreiro SG, Sobrinho-Simões M, Monteiro MP, Pignatelli D

Telomerase and N-Cadherin Differential Importance in Adrenocortical Cancers and Adenomas. Journal of cellular biochemistry 118: 2064-2071, 2017.  [Article] 

 doi: 10.1002/jcb.25811 PMID: 27886397.

 

39. Canberk S, Pereira L, Batista R, Soares P, Maximo V, Simoes MS

DICER1 alterations are more frequent in oncocytic, follicular and rare aggressive variants than in classical papillary thyroid carcinoma Virchows Archiv 473: S67-S67, 2018.  [Meeting Abstract] 

.

 

40. Cameselle-Teijeiro J, Ferreira R, Caramés N, Abdulkader I, Máximo V, Soares P, Sobrinho-Simões M

Absence of the BRAF and the GRIM-19 Mutations in Oncocytic (Hurthle Cell) Solid Cell Nests of the Thyroid. American journal of clinical pathology 137: 612-8, 2012.  [Article] 

 doi: 10.1309/AJCPB0RXYPACLL5K PMID: 22431538.

 

41. de Vries MM, Celestino R, Castro P, Eloy C, Máximo V, van der Wal JE, Plukker JT, Links TP, Hofstra RM, Sobrinho-Simões M, Soares P

RET/PTC rearrangement is prevalent in follicular Hürthle cell carcinomas. Histopathology 61: 833-843, 2012.  [Article] 

 doi: 10.1111/j.1365-2559.2012.04276.x PMID: 22803838.

 

42. Máximo V, Soares P, Seruca R, Sobrinho-Simões M

Comments on: mutations in mitochondrial control region DNA in gastric tumours of Japanese patients, Tamura, et al. Eur J Cancer 1999, 35, 316-319. European journal of cancer (Oxford, England : 1990) 35: 1407-8, 1999.  [Letter] 

 PMID: 10658535.

 

43. Meireles AM, Preto A, Rocha AS, Rebocho AP, Máximo V, Pereira-Castro I, Moreira S, Feijão T, Botelho T, Marques R, Trovisco V, Cirnes L, Alves C, Velho S, Soares P, Sobrinho-Simões M

Molecular and genotypic characterization of human thyroid follicular cell carcinoma-derived cell lines. Thyroid : official journal of the American Thyroid Association 17: 707-15, 2007.  [Article] 

 doi: 10.1089/thy.2007.0097 PMID: 17725429.

 

44. Vinagre J, Pinto V, Celestino R, Reis M, Pópulo H, Boaventura P, Melo M, Catarino T, Lima J, Lopes JM, Máximo V, Sobrinho-Simões M, Soares P

Telomerase promoter mutations in cancer: an emerging molecular biomarker? Virchows Archiv : an international journal of pathology 465: 119-33, 2014.  [Review] 

 doi: 10.1007/s00428-014-1608-4 PMID: 25048572.

 

45. Cameselle-Teijeiro J, Ferreira R, Caramés N, Abdulkader I, Máximo V, Soares P, Sobrinho-Simões M

Absence of both the BRAF and the GRIM-19 mutations in oncocytic (Hürthle cell) solid cell nests of the thyroid American journal of clinical pathology  1, 2011.  [] 

.

 

46. Gonçalves AP, Videira A, Soares P, Máximo V

Orthovanadate-induced cell death in RET/PTC1-harboring cancer cells involves the activation of caspases and altered signaling through PI3K/Akt/mTOR. Life sciences 89: 371-7, 2011.  [Article] 

 doi: 10.1016/j.lfs.2011.07.004 PMID: 21807000.

 

47. Soares P, Lima J, Preto A, Castro P, Vinagre J, Celestino R, Couto JP, Prazeres H, Eloy C, Máximo V, Sobrinho-Simões M

Genetic alterations in poorly differentiated and undifferentiated thyroid carcinomas. Current genomics 12: 609-17, 2011.  [Article] 

 doi: 10.2174/138920211798120853 PMID: 22654560.

 

48. Soares P, Lima J, Preto A, Castro P, Vinagre J, Celestino R, Couto JP, Prazeres H, Eloy C, Máximo V, Sobrinho-Simões M

Alterations in Poorly Differentiated and Unddiferentiated Thyroid Carcinomas Current genomics  1, 2011.  [] 

.

 

49. Couto JP, Prazeres H, Castro P, Lima J, Máximo V, Soares P, Sobrinho-Simões M

How molecular pathology is changing and will change the therapeutics of patients with follicular cell-derived thyroid cancer. Journal of clinical pathology 62: 414-21, 2009.  [Review] 

 doi: 10.1136/jcp.2008.055343 PMID: 19147628.

 

50. Bertagnolli AC, Soares P, van Asch B, Amorim A, Cirnes L, Máximo V, Cassali GD

An assessment of the clonality of the components of canine mixed mammary tumours by mitochondrial DNA analysis. Veterinary journal (London, England : 1997) 182: 269-74, 2009.  [Article] 

 doi: 10.1016/j.tvjl.2008.07.005 PMID: 18752974.

 

51. Máximo V, Lima J, Soares P, Sobrinho-Simões M

Mitochondria and cancer. Virchows Archiv : an international journal of pathology 454: 481-95, 2009.  [Review] 

 doi: 10.1007/s00428-009-0766-2 PMID: 19343360.

 

52. Máximo V, Preto A, Crespo A, Rocha AS, Machado JC, Soares P, Sobrinho-Simões M

Core I gene is overexpressed in Hürthle and non-Hürthle cell microfollicular adenomas and follicular carcinomas of the thyroid. BMC cancer 4: 12, 2004.  [Article] 

 doi: 10.1186/1471-2407-4-12 PMID: 15043758.

 

53. Sobrinho-Simões M, Máximo V

Warthin's tumour. Virchows Archiv : an international journal of pathology 448: 877-8, 2006.  [Letter] 

 doi: 10.1007/s00428-005-0052-x PMID: 16609912.

 

54. Trovisco V, Soares P, Preto A, de Castro IV, Lima J, Castro P, Máximo V, Botelho T, Moreira S, Meireles AM, Magalhães J, Abrosimov A, Cameselle-Teijeiro J, Sobrinho-Simões M

Type and prevalence of BRAF mutations are closely associated with papillary thyroid carcinoma histotype and patients' age but not with tumour aggressiveness. Virchows Archiv : an international journal of pathology 446: 589-95, 2005.  [Article] 

 doi: 10.1007/s00428-005-1236-0 PMID: 15902486.

 

55. Sobrinho-Simões M, Preto A, Rocha AS, Castro P, Máximo V, Fonseca E, Soares P

Molecular pathology of well-differentiated thyroid carcinomas. Virchows Archiv : an international journal of pathology 447: 787-93, 2005.  [Review] 

 doi: 10.1007/s00428-005-0065-5 PMID: 16189702.

 

56. Sobrinho-Simões M, Máximo V, Rocha AS, Trovisco V, Castro P, Preto A, Lima J, Soares P

Intragenic mutations in thyroid cancer. Endocrinology and metabolism clinics of North America 37: 333-62, viii, 2008.  [Review] 

 doi: 10.1016/j.ecl.2008.02.004 PMID: 18502330.

 

57. Rocha AS, Soares P, Machado JC, Máximo V, Fonseca E, Franssila K, Sobrinho-Simões M

Mucoepidermoid carcinoma of the thyroid: a tumour histotype characterised by P-cadherin neoexpression and marked abnormalities of E-cadherin/catenins complex. Virchows Archiv : an international journal of pathology 440: 498-504, 2002.  [Article] 

 doi: 10.1007/s00428-002-0622-0 PMID: 12021924.

 

58. Lau E, Freitas P, Costa J, Batista R, Máximo V, Coelho R, Matos-Lima L, Eloy C, Carvalho D

Loss of mitochondrial SDHB expression: what is its role in diffuse thyroid lipomatosis? Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 47: 165-7, 2015.  [Article] 

 doi: 10.1055/s-0034-1398559 PMID: 25679879.

 

59. Almeida LMCA, Silva R, Cavadas B, Lima J, Pereira L, Soares P, Sobrinho-Simões M, Lopes JM, Máximo V

GLUT1, MCT1/4 and CD147 overexpression supports the metabolic reprogramming in papillary renal cell carcinoma. Histology and histopathology 32: 1029-1040, 2017.  [Article] 

 doi: 10.14670/HH-11-863 PMID: 28028797.

 

60. Celestino R, Lima J, Faustino A, Máximo V, Gouveia A, Vinagre J, Soares P, Lopes JM

A novel germline SDHB mutation in a gastrointestinal stromal tumor patient without bona fide features of the Carney-Stratakis dyad. Familial cancer 11: 189-94, 2012.  [Article] 

 doi: 10.1007/s10689-011-9499-x PMID: 22160509.

 

61. Máximo V, Sobrinho-Simões M

Hürthle cell tumours of the thyroid. A review with emphasis on mitochondrial abnormalities with clinical relevance. Virchows Archiv : an international journal of pathology 437: 107-15, 2000.  [Review] 

 PMID: 10993269.

 

62. Goncalves AP, Videira A, Maximo V, Soares P

Synergistic growth inhibition of cancer cells harboring the RET/PTC1 oncogene by staurosporine and rotenone involves enhanced cell death. Journal of biosciences 36: 639-48, 2011.  [Article] 

 PMID: 21857110.

 

63. Donner LR, Maximo V

Oncocytic Melanoma: A Study of a Rare Entity. The American Journal of dermatopathology 40: 854-856, 2018.  [Article] 

 doi: 10.1097/DAD.0000000000001183 PMID: 29771689.

 

64. Máximo V, Rios E, Sobrinho-Simões M

Oncocytic lesions of the thyroid, kidney, salivary glands, adrenal cortex, and parathyroid glands. International journal of surgical pathology 22: 33-6, 2014.  [Review] 

 doi: 10.1177/1066896913517938 PMID: 24406625.

 

65. Sobrinho-Simões M, Máximo V, Castro IV, Fonseca E, Soares P, Garcia-Rostan G, Oliveira MC

Hürthle (oncocytic) cell tumors of thyroid: etiopathogenesis, diagnosis and clinical significance. International journal of surgical pathology 13: 29-35, 2005.  [Review] 

 PMID: 15735852.

 

66. Máximo V, Lima J, Soares P, Botelho T, Gomes L, Sobrinho-Simões M

Mitochondrial D-Loop instability in thyroid tumours is not a marker of malignancy. Mitochondrion 5: 333-40, 2005.  [Article] 

 doi: 10.1016/j.mito.2005.06.003 PMID: 16183030.

 

67. Máximo V, Sores P, Rocha AS, Sobrinho-Simões M

The common deletion of mitochondrial DNA is found in goiters and thyroid tumors with and without oxyphil cell change. Ultrastructural pathology 22: 271-3, 1998.  [Letter] 

 PMID: 9793208.

 

68. Trovisco V, Soares P, Preto A, Castro P, Máximo V, Sobrinho-Simões M

Molecular genetics of papillary thyroid carcinoma: great expectations. Arquivos brasileiros de endocrinologia e metabologia 51: 643-53, 2007.  [Review] 

 PMID: 17891228.

 

69. Soares P, Máximo V, Sobrinho-Simöes M

Molecular pathology of papillary, follicular and Hürthle cell carcinomas of the thyroid. Arkhiv patologii 65: 45-7, 2003.  [] 

 PMID: 15357248.

 

70. Eloy C, Soares P, Máximo V, Sobrinho-Simões M

Thyroid and parathyroid glands Pathology of the Head and Neck  613-671, 2017.  [] 

 doi: 10.1007/978-3-662-49672-5_14.

 

71. Bertagnolli AC, Máximo V, Van Asch B, Amorim A, Cirnes L, Soares P, Cassali GD

Optimization of methods to assess mitochondrial DNA in archival paraffin-embedded tissues from mammary canine tumors Jornal  Brasileiro de  Patologia  305-308, 2008.  [] 

.